{"transactions":[{"id":739152,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T17:00:51.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to such option vest and become exercisable on October 1, 2026, January 1, 2027, and April 1, 2027, respectively, and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of the June 11, 2026 grant date or (ii) the next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer as a Director through each such date or, if earlier, such annual meeting."}],"balance_after":70000,"derivative":{"exercise_price":1.14,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001746473-26-000099","document":"wk-form4_1781298048.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633639/000174647326000099/wk-form4_1781298048.xml","form_type":"4"}},{"id":828043,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-25T17:07:11.000Z","date":"2026-03-24","kind":"grant","planned":false,"acquired":true,"shares":45867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":45867,"derivative":{"exercise_price":1.36,"expiration_date":"2036-03-24","underlying":"Common Stock","underlying_shares":45867},"source":{"system":"sec-edgar","filing":"0001193125-26-124325","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633639/000119312526124325/ownership.xml","form_type":"4"}},{"id":941835,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Share Units","published_at":"2026-01-09T23:53:13.000Z","date":"2026-01-09","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on January 9, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on January 9, 2027."}],"balance_after":20000,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-26-009235","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000119312526009235/ownership.xml","form_type":"4"}},{"id":941834,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2026-01-09T23:53:13.000Z","date":"2026-01-09","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on January 9, 2027, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":40000,"derivative":{"exercise_price":42.15,"expiration_date":"2036-01-08","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001193125-26-009235","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000119312526009235/ownership.xml","form_type":"4"}},{"id":1102396,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2025-06-25T01:35:16.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":185800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on June 23, 2026, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":185800,"derivative":{"exercise_price":31.49,"expiration_date":"2035-06-22","underlying":"Common Shares","underlying_shares":185800},"source":{"system":"sec-edgar","filing":"0000950170-25-089721","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000095017025089721/ownership.xml","form_type":"4"}},{"id":1117356,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2025-06-09T20:43:44.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to such option vest and become exercisable on October 1, 2025, January 1, 2026, and April 1, 2026, respectively,  and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of the June 5, 2025 grant date or (ii) the next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer as a Director through each such date or, if earlier, such annual meeting."}],"balance_after":30000,"derivative":{"exercise_price":1.61,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001746473-25-000127","document":"wk-form4_1749516208.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633639/000174647325000127/wk-form4_1749516208.xml","form_type":"4"}},{"id":1182501,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T09:01:38.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":36979,"price":0.98,"value":36239.42,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":36979,"derivative":{"exercise_price":0.98,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":36979},"source":{"system":"sec-edgar","filing":"0000950170-25-048899","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633639/000095017025048899/ownership.xml","form_type":"4"}},{"id":1476835,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2024-06-17T20:15:41.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":26764,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to such option vest and become exercisable on the first day of each calendar quarter for three calendar quarters following the June 13th, 2024 grant date and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of the June 13, 2024 grant date or (ii) the next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer as a Director through each such date or, if earlier, such annual meeting."}],"balance_after":26764,"derivative":{"exercise_price":13.06,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":26764},"source":{"system":"sec-edgar","filing":"0001746473-24-000103","document":"wk-form4_1718669734.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633639/000174647324000103/wk-form4_1718669734.xml","form_type":"4"}},{"id":1558203,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-28T16:33:15.000Z","date":"2024-03-26","kind":"grant","planned":false,"acquired":true,"shares":35219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":251405,"source":{"system":"sec-edgar","filing":"0000950170-24-038105","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633639/000095017024038105/ownership.xml","form_type":"4"}},{"id":1849411,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-20T18:41:59.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":13222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is 100% vested on June 16, 2024."}],"balance_after":13222,"derivative":{"exercise_price":1.34,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":13222},"source":{"system":"sec-edgar","filing":"0001209191-23-038606","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445499/000120919123038606/doc4.xml","form_type":"4"}},{"id":1861754,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T17:09:12.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to such option vest and become exercisable on the first day of each calendar quarter for three calendar quarters following the June 7th, 2023 grant date and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of the June 7th, 2023 grant date, or (ii) the 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer as a Director through each such date or, if earlier, such annual meeting."}],"balance_after":14000,"derivative":{"exercise_price":23.09,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-23-035511","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633639/000120919123035511/doc4.xml","form_type":"4"}},{"id":1919515,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-14T16:58:03.000Z","date":"2023-04-12","kind":"grant","planned":false,"acquired":true,"shares":20013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/3rd of the total shares on April 12, 2024 and then 1/36th of the total shares vests on each monthly anniversary thereafter, with 100% of the total shares vested and exercisable on April 12, 2026, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":20013,"derivative":{"exercise_price":1.42,"expiration_date":"2033-04-11","underlying":"Common Stock","underlying_shares":20013},"source":{"system":"sec-edgar","filing":"0001209191-23-024348","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445499/000120919123024348/doc4.xml","form_type":"4"}},{"id":1936516,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-28T16:41:45.000Z","date":"2023-03-24","kind":"grant","planned":false,"acquired":true,"shares":139355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":216186,"source":{"system":"sec-edgar","filing":"0001209191-23-021405","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633639/000120919123021405/doc4.xml","form_type":"4"}},{"id":1962514,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-08T16:36:37.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of March 6, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":22000,"derivative":{"exercise_price":31.11,"expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-23-017213","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633639/000120919123017213/doc4.xml","form_type":"4"}},{"id":2307121,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-04-04T16:15:47.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":66831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":76831,"source":{"system":"sec-edgar","filing":"0001140361-22-012914","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633639/000114036122012914/form4.xml","form_type":"4"}},{"id":2478529,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-09T16:18:18.000Z","date":"2021-12-08","kind":"purchase","acquired":true,"shares":10000,"price":9.3885,"value":93885.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.109 to $9.5561, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein"}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000899243-21-047525","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633639/000089924321047525/doc4.xml","form_type":"4"}},{"id":2544135,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":true}}],"security":"Stock Option (Right to buy)","published_at":"2021-10-12T19:47:51.000Z","date":"2021-10-07","kind":"grant","acquired":true,"shares":42191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest as to 1/3 of the shares covered by the option on each annual general meeting of the Issuer's stockholders following the October 7, 2021 grant date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":42191,"derivative":{"exercise_price":16,"expiration_date":"2031-10-07","underlying":"Common Stock","underlying_shares":42191},"source":{"system":"sec-edgar","filing":"0001140361-21-034425","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633639/000114036121034425/form4.xml","form_type":"4"}},{"id":2722896,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"U.S. Chief Commercial Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:21:57.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":75024,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Transaction Agreement, one-third of these share options vested and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration, and the remaining two-thirds were converted into an option to acquire Jazz ordinary shares (with any performance goals deemed fully satisfied), half of which will vest on March 2, 2022 and half of which will vest on March 2, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Transaction Agreement, one-third of these share options vested and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration, and the remaining two-thirds were converted into an option to acquire Jazz ordinary shares (with any performance goals deemed fully satisfied), half of which will vest on March 2, 2022 and half of which will vest on March 2, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":75024},"source":{"system":"sec-edgar","filing":"0000899243-21-018670","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018670/doc4.xml","form_type":"4"}},{"id":2722895,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"U.S. Chief Commercial Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:21:57.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":46896,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Transaction Agreement, one-third of these share options vested and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration, and the remaining two-thirds were converted into an option to acquire Jazz ordinary shares (with any performance goals deemed fully satisfied), half of which will vest on March 2, 2022 and half of which will vest on March 2, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Transaction Agreement, one-third of these share options vested and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration, and the remaining two-thirds were converted into an option to acquire Jazz ordinary shares (with any performance goals deemed fully satisfied), half of which will vest on March 2, 2022 and half of which will vest on March 2, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":46896},"source":{"system":"sec-edgar","filing":"0000899243-21-018670","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018670/doc4.xml","form_type":"4"}},{"id":2722894,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"U.S. Chief Commercial Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:21:57.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":177180,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":177180},"source":{"system":"sec-edgar","filing":"0000899243-21-018670","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018670/doc4.xml","form_type":"4"}},{"id":2722893,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"U.S. Chief Commercial Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:21:57.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":106320,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":106320},"source":{"system":"sec-edgar","filing":"0000899243-21-018670","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018670/doc4.xml","form_type":"4"}},{"id":2722892,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"U.S. Chief Commercial Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:21:57.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":98040,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":98040},"source":{"system":"sec-edgar","filing":"0000899243-21-018670","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018670/doc4.xml","form_type":"4"}},{"id":2722891,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"U.S. Chief Commercial Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:21:57.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":22068,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":22068},"source":{"system":"sec-edgar","filing":"0000899243-21-018670","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018670/doc4.xml","form_type":"4"}},{"id":2722890,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"U.S. Chief Commercial Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:21:57.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":54192,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."}],"balance_after":0,"derivative":{"exercise_price":15.3017,"expiration_date":"2029-05-28","underlying":"Ordinary Shares","underlying_shares":54192},"source":{"system":"sec-edgar","filing":"0000899243-21-018670","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018670/doc4.xml","form_type":"4"}},{"id":2722889,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"U.S. Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-07T16:21:57.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":5556,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 5, 2021, Jazz Pharmaceuticals Public Limited Company, a public limited company incorporated in the Republic of Ireland (\"Jazz\"), Jazz Pharmaceuticals UK Holdings Limited, a private limited company incorporated in England and Wales and an indirect wholly owned subsidiary of Jazz (\"Bidco\") and the DR Nominee (as defined in the Transaction Agreement) acquired all outstanding ordinary shares, par value British Pound Sterling 0.001 per share, of GW Pharmaceuticals plc, a public limited company incorporated in England and Wales (the \"Company\"), by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006 (the \"Scheme of Arrangement\") (continued in footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Scheme of Arrangement, Scheme Shareholders (as defined in the Scheme of Arrangement) became entitled to receive for each Scheme Share (as defined in the Scheme of Arrangement) held by them an amount equal to $16.66 2/3 in cash plus 0.010030 ordinary shares, nominal value $0.0001 per share, of Jazz (\"Jazz ordinary shares\"). The transaction is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on March 15, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-018670","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018670/doc4.xml","form_type":"4"}},{"id":2808515,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"U.S. Chief Commercial Officer"}}],"security":"Share Options","published_at":"2021-03-04T21:05:48.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":46896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"security","element":"securityTitle","label":"F6","text":"The share numbers underlying options granted on February 22, 2021 and reported on the reporting person's form 4 filed on February 24, 2021 were amended as of March 2, 2021 and as reported in this form 4."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.41 U.S. Dollars as of February 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These share options will vest in four equal annual installments beginning on February 22, 2022 and be automatically exercised upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These share options will vest in four equal annual installments beginning on February 22, 2022 and be automatically exercised upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."}],"balance_after":46896,"derivative":{"exercise_price":0.0014,"underlying":"Ordinary Shares","underlying_shares":46896},"source":{"system":"sec-edgar","filing":"0000899243-21-010022","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321010022/doc4.xml","form_type":"4"}},{"id":2808514,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"U.S. Chief Commercial Officer"}}],"security":"Share Options","published_at":"2021-03-04T21:05:48.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":75024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on February 22, 2024 if certain performance conditions are satisfied."},{"field":"security","element":"securityTitle","label":"F6","text":"The share numbers underlying options granted on February 22, 2021 and reported on the reporting person's form 4 filed on February 24, 2021 were amended as of March 2, 2021 and as reported in this form 4."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.41 U.S. Dollars as of February 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on February 22, 2024 if certain performance conditions are satisfied."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on February 22, 2024 if certain performance conditions are satisfied."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."}],"balance_after":75024,"derivative":{"exercise_price":0.0014,"underlying":"Ordinary Shares","underlying_shares":75024},"source":{"system":"sec-edgar","filing":"0000899243-21-010022","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321010022/doc4.xml","form_type":"4"}},{"id":2835515,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"U.S. Chief Commercial Officer"}}],"security":"Share Options","published_at":"2021-02-24T18:53:37.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":75024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.41 U.S. Dollars as of February 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These share options will vest in four equal annual installments beginning on February 22, 2022 and be automatically exercised upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These share options will vest in four equal annual installments beginning on February 22, 2022 and be automatically exercised upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."}],"balance_after":75024,"derivative":{"exercise_price":0.0014,"underlying":"Ordinary Shares","underlying_shares":75024},"source":{"system":"sec-edgar","filing":"0000899243-21-008099","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321008099/doc4.xml","form_type":"4"}},{"id":2835514,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"U.S. Chief Commercial Officer"}}],"security":"Share Options","published_at":"2021-02-24T18:53:37.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":46896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on February 22, 2024 if certain performance conditions are satisfied."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.41 U.S. Dollars as of February 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on February 22, 2024 if certain performance conditions are satisfied."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on February 22, 2024 if certain performance conditions are satisfied."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."}],"balance_after":46896,"derivative":{"exercise_price":0.0014,"underlying":"Ordinary Shares","underlying_shares":46896},"source":{"system":"sec-edgar","filing":"0000899243-21-008099","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321008099/doc4.xml","form_type":"4"}},{"id":3114499,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-10T11:15:48.000Z","date":"2020-06-10","kind":"other","acquired":false,"shares":35468,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of in connection with a tender offer made pursuant to an agreement and plan of merger among Issuer, Berlin-Chemie AG, and Mercury Merger Sub, Inc., dated as of May 3, 2020, in exchange for $11.50 per share, net to the holder in cash, plus one contractual contingent value right (\"CVR\") per share.  Each CVR represents the right to receive a payment of $1.00 in cash upon the achievement of a certain milestone relating to the first sale of ELZONRIS in any one of certain countries following a marketing authorization approval by the European Commission. The CVR milestone must be achieved on or prior to December 31, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-071831","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465920071831/a4.xml","form_type":"4"}},{"id":3118511,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"U.S. Chief Commercial Officer"}}],"security":"Share Options","published_at":"2020-06-08T20:00:25.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":106320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.26 U.S. Dollars as of June 4, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These share options will vest in four equal annual installments beginning on June 4, 2021 and be automatically exercised upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These share options will vest in four equal annual installments beginning on June 4, 2021 and be automatically exercised upon vesting."}],"balance_after":106320,"derivative":{"exercise_price":0.0013,"underlying":"Ordinary Shares","underlying_shares":106320},"source":{"system":"sec-edgar","filing":"0000899243-20-015687","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320015687/doc4.xml","form_type":"4"}},{"id":3118510,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"U.S. Chief Commercial Officer"}}],"security":"Share Options","published_at":"2020-06-08T20:00:25.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":177180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on June 4, 2023 if certain performance conditions are satisfied."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.26 U.S. Dollars as of June 4, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on June 4, 2023 if certain performance conditions are satisfied."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on June 4, 2023 if certain performance conditions are satisfied."}],"balance_after":177180,"derivative":{"exercise_price":0.0013,"underlying":"Ordinary Shares","underlying_shares":177180},"source":{"system":"sec-edgar","filing":"0000899243-20-015687","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320015687/doc4.xml","form_type":"4"}},{"id":3130426,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"U.S. Chief Commercial Officer"}}],"security":"Stock Options","published_at":"2020-05-29T20:00:24.000Z","date":"2020-05-28","kind":"exercise","acquired":false,"shares":7356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.23 U.S. Dollars as of May 28, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.0012,"exercise_date":"2020-05-28","expiration_date":"2020-05-28","underlying":"Ordinary Shares","underlying_shares":7356},"source":{"system":"sec-edgar","filing":"0000899243-20-014631","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320014631/doc4.xml","form_type":"4"}},{"id":3130425,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"U.S. Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-05-29T20:00:24.000Z","date":"2020-05-28","kind":"tax_withholding","acquired":true,"shares":1800,"price":10.54,"value":18972.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represented by ADS."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":5556,"source":{"system":"sec-edgar","filing":"0000899243-20-014631","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320014631/doc4.xml","form_type":"4"}},{"id":3130424,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"U.S. Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-05-29T20:00:24.000Z","date":"2020-05-28","kind":"exercise","acquired":true,"shares":7356,"price":0.0012,"value":8.8272,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.23 U.S. Dollars as of May 28, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Column 5 of Table I of the reporting person's form 4 filed with the SEC on May 30, 2020 includes 29,424 ordinary shares underlying RSU style stock options granted on March 28, 2019 pursuant to the Issuer's Long-Term Incentive Plan, vesting automatically in four equal annual installments beginning on May 28, 2020.  These ordinary shares have been excluded from Column 5 of this form 4 and will be reported as each tranche is vested and automatically exercised.  The vesting and exercise of the first tranche is reported on this form 4."}],"balance_after":7356,"source":{"system":"sec-edgar","filing":"0000899243-20-014631","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320014631/doc4.xml","form_type":"4"}},{"id":3475929,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-28T17:15:55.000Z","date":"2019-06-25","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted shares will vest according to the following schedule: 5,000 shares on 6/25/2020, 5,000 shares on 6/25/2021 and 5,000 shares on 6/25/2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of the 35,468 shares, 28,645 shares are restricted stock."}],"balance_after":35468,"source":{"system":"sec-edgar","filing":"0001104659-19-038307","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465919038307/a4.xml","form_type":"4"}},{"id":3507398,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"U.S. Chief Commercial Officer"}}],"security":"Stock Options","published_at":"2019-05-30T20:00:49.000Z","date":"2019-05-28","kind":"grant","acquired":true,"shares":98040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Performance based stock options granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.27 U.S. Dollars as of May 28, 2019."}],"balance_after":98040,"derivative":{"exercise_price":0.0013,"exercise_date":"2022-05-28","expiration_date":"2022-05-28","underlying":"Ordinary Shares","underlying_shares":98040},"source":{"system":"sec-edgar","filing":"0000899243-19-015229","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319015229/doc4.xml","form_type":"4"}},{"id":3507397,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"U.S. Chief Commercial Officer"}}],"security":"Stock Options","published_at":"2019-05-30T20:00:49.000Z","date":"2019-05-28","kind":"grant","acquired":true,"shares":54192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan.  The reported options are options to purchase American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The exercise price reported is price per ordinary share converted from price per ADS ($183.62)."}],"balance_after":54192,"derivative":{"exercise_price":15.3,"exercise_date":"2022-05-28","expiration_date":"2029-05-28","underlying":"Ordinary Shares","underlying_shares":54192},"source":{"system":"sec-edgar","filing":"0000899243-19-015229","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319015229/doc4.xml","form_type":"4"}},{"id":3507396,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"U.S. Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2019-05-30T20:00:49.000Z","date":"2019-05-28","kind":"grant","acquired":true,"shares":29424,"price":0.0013,"value":38.2512,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock units (\"RSUs\") pursuant to the Issuer's Long-Term Incentive Plan, which will vest automatically in four equal annual installments beginning on May 28, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.27 U.S. Dollars as of May 28, 2019."}],"balance_after":29424,"source":{"system":"sec-edgar","filing":"0000899243-19-015229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319015229/doc4.xml","form_type":"4"}},{"id":3747880,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2018-11-30T18:32:35.000Z","date":"2018-11-29","kind":"sale","acquired":false,"shares":7000,"price":62.88,"value":440160.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $62.8711 to $62.9508. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":72556,"source":{"system":"sec-edgar","filing":"0001203311-18-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000097/edgardoc.xml","form_type":"4"}},{"id":3755272,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2018-11-21T18:42:27.000Z","date":"2018-11-21","kind":"sale","acquired":false,"shares":4167,"price":56.6845,"value":236204.3115,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":79556,"source":{"system":"sec-edgar","filing":"0001203311-18-000095","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000095/edgardoc.xml","form_type":"4"}},{"id":3827644,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-09-04T20:41:24.000Z","date":"2018-08-30","kind":"grant","acquired":true,"shares":42984,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares shall vest at a rate of 25% one year from the grant date and monthly thereafter until all shares are fully vested four years from the grant date."}],"balance_after":42984,"derivative":{"exercise_price":76.86,"expiration_date":"2028-08-30","underlying":"Common Stock","underlying_shares":42984},"source":{"system":"sec-edgar","filing":"0001203311-18-000073","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000073/edgardoc.xml","form_type":"4"}},{"id":3827643,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2018-09-04T20:41:24.000Z","date":"2018-08-30","kind":"grant","acquired":true,"shares":1301,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares shall vest at a rate of 25% one year from the grant date and monthly thereafter until all shares are fully vested four years from the grant date."}],"balance_after":1301,"derivative":{"exercise_price":76.86,"expiration_date":"2028-08-30","underlying":"Common Stock","underlying_shares":1301},"source":{"system":"sec-edgar","filing":"0001203311-18-000073","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000073/edgardoc.xml","form_type":"4"}},{"id":3827642,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2018-09-04T20:41:24.000Z","date":"2018-08-30","kind":"grant","acquired":true,"shares":18644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares represent restricted stock units and will be settled in common stock upon vesting."},{"field":"date","element":"transactionDate","label":"F2","text":"Shares shall vest at a rate of 25% on each anniversary of the grant date until all shares are fully vested four years from the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":83723,"source":{"system":"sec-edgar","filing":"0001203311-18-000073","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000073/edgardoc.xml","form_type":"4"}},{"id":3830790,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2018-08-29T19:32:57.000Z","date":"2018-08-27","kind":"sale","acquired":false,"shares":4784,"price":74.2318,"value":355124.9312,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":65079,"source":{"system":"sec-edgar","filing":"0001203311-18-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000061/edgardoc.xml","form_type":"4"}},{"id":3884840,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-22T21:30:37.000Z","date":"2018-06-21","kind":"grant","acquired":true,"shares":20468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted shares will vest according to the following schedule: 6,823 shares on 6/21/2019, 6,823 shares on 6/21/2020 and 6,822 shares on 6/21/2021."}],"balance_after":20468,"source":{"system":"sec-edgar","filing":"0001104659-18-041868","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465918041868/a4.xml","form_type":"4"}},{"id":3894416,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-06-14T18:31:32.000Z","date":"2018-06-12","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares shall vest at a rate of 25% on 2/03/2016 and monthly thereafter until all the shares are fully vested on 2/03/2019."}],"balance_after":1583,"derivative":{"exercise_price":31.37,"expiration_date":"2025-02-03","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001203311-18-000051","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000051/edgardoc.xml","form_type":"4"}},{"id":3894415,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-06-14T18:31:32.000Z","date":"2018-06-12","kind":"exercise","acquired":false,"shares":926,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares vested at a rate of 25% on 8/20/13 and monthly thereafter until all shares were fully vested on 8/20/16."}],"balance_after":0,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":926},"source":{"system":"sec-edgar","filing":"0001203311-18-000051","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000051/edgardoc.xml","form_type":"4"}},{"id":3894414,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-06-14T18:31:32.000Z","date":"2018-06-12","kind":"exercise","acquired":false,"shares":892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares vested at a rate of 25% on 10/29/11 and monthly thereafter until all the shares were fully vested on 10/29/14."}],"balance_after":0,"derivative":{"exercise_price":16.41,"expiration_date":"2020-10-29","underlying":"Common Stock","underlying_shares":892},"source":{"system":"sec-edgar","filing":"0001203311-18-000051","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000051/edgardoc.xml","form_type":"4"}},{"id":3894413,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-06-14T18:31:32.000Z","date":"2018-06-12","kind":"exercise","acquired":false,"shares":268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares vested at a rate of 25% on 8/24/12 and monthly thereafter until all the shares were fully vested on 8/24/15."}],"balance_after":0,"derivative":{"exercise_price":15.46,"expiration_date":"2021-08-24","underlying":"Common Stock","underlying_shares":268},"source":{"system":"sec-edgar","filing":"0001203311-18-000051","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000051/edgardoc.xml","form_type":"4"}},{"id":3894412,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2018-06-14T18:31:32.000Z","date":"2018-06-12","kind":"sale","acquired":false,"shares":1250,"price":69.027,"value":86283.75,"ownership":{"direct":true},"balance_after":69863,"source":{"system":"sec-edgar","filing":"0001203311-18-000051","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000051/edgardoc.xml","form_type":"4"}},{"id":3894411,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2018-06-14T18:31:32.000Z","date":"2018-06-12","kind":"sale","acquired":false,"shares":718,"price":68.9,"value":49470.2,"ownership":{"direct":true},"balance_after":71113,"source":{"system":"sec-edgar","filing":"0001203311-18-000051","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000051/edgardoc.xml","form_type":"4"}},{"id":3894410,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2018-06-14T18:31:32.000Z","date":"2018-06-12","kind":"sale","acquired":false,"shares":8000,"price":69,"value":552000.0,"ownership":{"direct":true},"balance_after":71831,"source":{"system":"sec-edgar","filing":"0001203311-18-000051","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000051/edgardoc.xml","form_type":"4"}},{"id":3894409,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2018-06-14T18:31:32.000Z","date":"2018-06-12","kind":"exercise","acquired":true,"shares":8000,"price":31.37,"value":250960.0,"ownership":{"direct":true},"balance_after":79831,"source":{"system":"sec-edgar","filing":"0001203311-18-000051","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000051/edgardoc.xml","form_type":"4"}},{"id":3894408,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2018-06-14T18:31:32.000Z","date":"2018-06-12","kind":"sale","acquired":false,"shares":926,"price":69,"value":63894.0,"ownership":{"direct":true},"balance_after":71831,"source":{"system":"sec-edgar","filing":"0001203311-18-000051","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000051/edgardoc.xml","form_type":"4"}},{"id":3894407,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2018-06-14T18:31:32.000Z","date":"2018-06-12","kind":"exercise","acquired":true,"shares":926,"price":26.1,"value":24168.6,"ownership":{"direct":true},"balance_after":72757,"source":{"system":"sec-edgar","filing":"0001203311-18-000051","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000051/edgardoc.xml","form_type":"4"}},{"id":3894406,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2018-06-14T18:31:32.000Z","date":"2018-06-12","kind":"sale","acquired":false,"shares":268,"price":69,"value":18492.0,"ownership":{"direct":true},"balance_after":71831,"source":{"system":"sec-edgar","filing":"0001203311-18-000051","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000051/edgardoc.xml","form_type":"4"}},{"id":3894405,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2018-06-14T18:31:32.000Z","date":"2018-06-12","kind":"exercise","acquired":true,"shares":268,"price":15.46,"value":4143.28,"ownership":{"direct":true},"balance_after":72099,"source":{"system":"sec-edgar","filing":"0001203311-18-000051","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000051/edgardoc.xml","form_type":"4"}},{"id":3894404,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2018-06-14T18:31:32.000Z","date":"2018-06-12","kind":"sale","acquired":false,"shares":892,"price":69,"value":61548.0,"ownership":{"direct":true},"balance_after":71831,"source":{"system":"sec-edgar","filing":"0001203311-18-000051","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000051/edgardoc.xml","form_type":"4"}},{"id":3894403,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2018-06-14T18:31:32.000Z","date":"2018-06-12","kind":"exercise","acquired":true,"shares":892,"price":16.41,"value":14637.72,"ownership":{"direct":true},"balance_after":72723,"source":{"system":"sec-edgar","filing":"0001203311-18-000051","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000051/edgardoc.xml","form_type":"4"}},{"id":3937419,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-05-11T19:59:54.000Z","date":"2018-05-09","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares vested at a rate of 25% on 10/29/2011 and monthly thereafter until all the shares were fully vested on 10/29/2014."}],"balance_after":892,"derivative":{"exercise_price":16.41,"expiration_date":"2020-10-29","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001203311-18-000026","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000026/edgardoc.xml","form_type":"4"}},{"id":3937418,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-05-11T19:59:54.000Z","date":"2018-05-09","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares vested at a rate of 25% on 8/24/2012 and monthly thereafter until all the shares were fully vested on 8/24/2015."}],"balance_after":268,"derivative":{"exercise_price":15.46,"expiration_date":"2021-08-24","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001203311-18-000026","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000026/edgardoc.xml","form_type":"4"}},{"id":3937417,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2018-05-11T19:59:54.000Z","date":"2018-05-09","kind":"sale","acquired":false,"shares":9000,"price":55.3314,"value":497982.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $55.33 to $55.38. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 54 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on January 31, 2018."}],"balance_after":71831,"source":{"system":"sec-edgar","filing":"0001203311-18-000026","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000026/edgardoc.xml","form_type":"4"}},{"id":3937416,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2018-05-11T19:59:54.000Z","date":"2018-05-09","kind":"exercise","acquired":true,"shares":2000,"price":15.46,"value":30920.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 54 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on January 31, 2018."}],"balance_after":80831,"source":{"system":"sec-edgar","filing":"0001203311-18-000026","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000026/edgardoc.xml","form_type":"4"}},{"id":3937415,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2018-05-11T19:59:54.000Z","date":"2018-05-09","kind":"exercise","acquired":true,"shares":7000,"price":16.41,"value":114870.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 54 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on January 31, 2018."}],"balance_after":78831,"source":{"system":"sec-edgar","filing":"0001203311-18-000026","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000026/edgardoc.xml","form_type":"4"}},{"id":3944568,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2018-05-07T19:08:55.000Z","date":"2018-05-03","kind":"sale","acquired":false,"shares":4000,"price":53.8096,"value":215238.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects sales of Common Stock executed in multiple transactions at prices ranging from $53.78 to $53.85. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission Staff, the Issuer or a Security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":71831,"source":{"system":"sec-edgar","filing":"0001203311-18-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000024/edgardoc.xml","form_type":"4"}},{"id":3985440,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Non-qualified Stock Option (Right to buy)","published_at":"2018-03-22T21:36:39.000Z","date":"2018-03-20","kind":"grant","acquired":true,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 9, 2016, the reporting person was granted an option to purchase 8,333 options of common stock.  The performance criteria for this grant were met as of March 20, 2018 and the option shall vest in four (4) equal tranches on the first, second, third and fourth anniversaries of March 20, 2018 subject to continuous service with the Company as of each vesting date."}],"balance_after":8333,"derivative":{"exercise_price":34.2,"expiration_date":"2026-05-09","underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0000899243-18-008416","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924318008416/doc4.xml","form_type":"4"}},{"id":4072485,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2018-02-07T20:17:37.000Z","date":"2018-02-05","kind":"disposition_to_issuer","acquired":false,"shares":1399,"price":55.5796,"value":77755.8604,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":75831,"source":{"system":"sec-edgar","filing":"0001203311-18-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000006/edgardoc.xml","form_type":"4"}},{"id":4213819,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-09-08T19:32:53.000Z","date":"2017-09-06","kind":"exercise","acquired":false,"shares":5024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares vested at a rate of 25% on August 24, 2012 and monthly thereafter until all the shares are fully vested on August 24, 2015."}],"balance_after":2268,"derivative":{"exercise_price":15.46,"expiration_date":"2021-08-24","underlying":"Common Stock","underlying_shares":5024},"source":{"system":"sec-edgar","filing":"0001203311-17-000074","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000074/edgardoc.xml","form_type":"4"}},{"id":4213818,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-09-08T19:32:53.000Z","date":"2017-09-06","kind":"exercise","acquired":false,"shares":5024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares vested at a rate of 25% on October 29, 2011 and monthly thereafter until all the shares are fully vested on October 29, 2014."}],"balance_after":0,"derivative":{"exercise_price":16.41,"expiration_date":"2020-10-29","underlying":"Common Stock","underlying_shares":5024},"source":{"system":"sec-edgar","filing":"0001203311-17-000074","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000074/edgardoc.xml","form_type":"4"}},{"id":4213817,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2017-09-08T19:32:53.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":5024,"price":51.944,"value":260966.656,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":77230,"source":{"system":"sec-edgar","filing":"0001203311-17-000074","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000074/edgardoc.xml","form_type":"4"}},{"id":4213816,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2017-09-08T19:32:53.000Z","date":"2017-09-06","kind":"exercise","acquired":true,"shares":5024,"price":15.46,"value":77671.04,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":82254,"source":{"system":"sec-edgar","filing":"0001203311-17-000074","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000074/edgardoc.xml","form_type":"4"}},{"id":4213815,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2017-09-08T19:32:53.000Z","date":"2017-09-06","kind":"exercise","acquired":true,"shares":5024,"price":16.41,"value":82443.84,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":77230,"source":{"system":"sec-edgar","filing":"0001203311-17-000074","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000074/edgardoc.xml","form_type":"4"}},{"id":4218262,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-09-05T19:23:08.000Z","date":"2017-08-31","kind":"exercise","acquired":false,"shares":2907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares vested at a rate of 25% on 2/29/2013 and monthly thereafter until all the shares were fully vested on 2/29/2016."}],"balance_after":0,"derivative":{"exercise_price":18.46,"expiration_date":"2022-02-28","underlying":"Common Stock","underlying_shares":2907},"source":{"system":"sec-edgar","filing":"0001203311-17-000070","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000070/edgardoc.xml","form_type":"4"}},{"id":4218261,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2017-09-05T19:23:08.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":4662,"price":52.5084,"value":244794.1608,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":72206,"source":{"system":"sec-edgar","filing":"0001203311-17-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000070/edgardoc.xml","form_type":"4"}},{"id":4218260,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2017-09-05T19:23:08.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":2907,"price":52.5188,"value":152672.1516,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $52.5175 to $52.52. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":76868,"source":{"system":"sec-edgar","filing":"0001203311-17-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000070/edgardoc.xml","form_type":"4"}},{"id":4218259,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2017-09-05T19:23:08.000Z","date":"2017-08-31","kind":"exercise","acquired":true,"shares":2907,"price":18.46,"value":53663.22,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":79775,"source":{"system":"sec-edgar","filing":"0001203311-17-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000070/edgardoc.xml","form_type":"4"}},{"id":4221843,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2017-08-30T19:18:55.000Z","date":"2017-08-28","kind":"sale","acquired":false,"shares":1788,"price":47.8945,"value":85635.366,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":76868,"source":{"system":"sec-edgar","filing":"0001203311-17-000058","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000058/edgardoc.xml","form_type":"4"}},{"id":4229793,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-08-18T20:12:34.000Z","date":"2017-08-17","kind":"grant","acquired":true,"shares":40344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares shall vest at a rate of 25% one year from grant date and monthly thereafter until all shares are fully vested four years form grant date."}],"balance_after":40344,"derivative":{"exercise_price":46.37,"expiration_date":"2027-08-17","underlying":"Common Stock","underlying_shares":40344},"source":{"system":"sec-edgar","filing":"0001203311-17-000042","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000042/edgardoc.xml","form_type":"4"}},{"id":4229792,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-08-18T20:12:34.000Z","date":"2017-08-17","kind":"grant","acquired":true,"shares":2156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares shall vest at a rate of 25% one year from grant date and monthly thereafter until all shares are fully vested four years form grant date."}],"balance_after":2156,"derivative":{"exercise_price":46.37,"expiration_date":"2027-08-17","underlying":"Common Stock","underlying_shares":2156},"source":{"system":"sec-edgar","filing":"0001203311-17-000042","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000042/edgardoc.xml","form_type":"4"}},{"id":4229791,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2017-08-18T20:12:34.000Z","date":"2017-08-17","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares represent restricted stock units and will be settled in common stock upon vesting."},{"field":"date","element":"transactionDate","label":"F2","text":"Restricted stock units shall vest in full three (3) years from grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":78656,"source":{"system":"sec-edgar","filing":"0001203311-17-000042","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000042/edgardoc.xml","form_type":"4"}},{"id":4239187,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-08-09T18:52:01.000Z","date":"2017-08-07","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares vested at a rate of 25% on 2/28/2013 and monthly thereafter until all the shares were fully vested on 2/28/2016."}],"balance_after":2907,"derivative":{"exercise_price":18.46,"expiration_date":"2022-02-28","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001203311-17-000038","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000038/edgardoc.xml","form_type":"4"}},{"id":4239186,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2017-08-09T18:52:01.000Z","date":"2017-08-07","kind":"sale","acquired":false,"shares":6000,"price":49.185,"value":295110.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 105 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on July 31, 2017."}],"balance_after":61656,"source":{"system":"sec-edgar","filing":"0001203311-17-000038","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000038/edgardoc.xml","form_type":"4"}},{"id":4239185,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2017-08-09T18:52:01.000Z","date":"2017-08-07","kind":"exercise","acquired":true,"shares":6000,"price":18.46,"value":110760.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 105 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on July 31, 2017."}],"balance_after":67656,"source":{"system":"sec-edgar","filing":"0001203311-17-000038","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000038/edgardoc.xml","form_type":"4"}},{"id":4515698,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2016-12-20T19:48:16.000Z","date":"2016-12-16","kind":"exercise","acquired":false,"shares":3100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares vested at a rate of 25% on 10/29/11 and monthly thereafter until all the shares were fully vested on 10/29/14."}],"balance_after":5024,"derivative":{"exercise_price":16.41,"expiration_date":"2020-10-29","underlying":"Common Stock","underlying_shares":3100},"source":{"system":"sec-edgar","filing":"0001203311-16-000185","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331116000185/edgardoc.xml","form_type":"4"}},{"id":4515697,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2016-12-20T19:48:16.000Z","date":"2016-12-16","kind":"exercise","acquired":true,"shares":3100,"price":16.41,"value":50871.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":61604,"source":{"system":"sec-edgar","filing":"0001203311-16-000185","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331116000185/edgardoc.xml","form_type":"4"}},{"id":4520783,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-12-15T19:26:44.000Z","date":"2016-12-13","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares vested at a rate of 25% on 8/20/13 and monthly thereafter until all shares were fully vested on 8/20/16."}],"balance_after":926,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001203311-16-000183","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331116000183/edgardoc.xml","form_type":"4"}},{"id":4520782,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2016-12-15T19:26:44.000Z","date":"2016-12-13","kind":"exercise","acquired":false,"shares":2761,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares vested at a rate of 25% on 2/28/13 and monthly thereafter until all shares were fully vested on 2/28/16."}],"balance_after":0,"derivative":{"exercise_price":18.46,"expiration_date":"2022-02-28","underlying":"Common Stock","underlying_shares":2761},"source":{"system":"sec-edgar","filing":"0001203311-16-000183","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331116000183/edgardoc.xml","form_type":"4"}},{"id":4520781,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2016-12-15T19:26:44.000Z","date":"2016-12-13","kind":"sale","acquired":false,"shares":1194,"price":64.349,"value":76832.706,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $63.75 to $64.55. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":58504,"source":{"system":"sec-edgar","filing":"0001203311-16-000183","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331116000183/edgardoc.xml","form_type":"4"}},{"id":4520780,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2016-12-15T19:26:44.000Z","date":"2016-12-13","kind":"exercise","acquired":true,"shares":2761,"price":18.46,"value":50968.06,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":59698,"source":{"system":"sec-edgar","filing":"0001203311-16-000183","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331116000183/edgardoc.xml","form_type":"4"}},{"id":4520779,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2016-12-15T19:26:44.000Z","date":"2016-12-13","kind":"sale","acquired":false,"shares":8806,"price":63.2525,"value":557001.515,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $62.73 to $63.59. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":56937,"source":{"system":"sec-edgar","filing":"0001203311-16-000183","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331116000183/edgardoc.xml","form_type":"4"}},{"id":4520778,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2016-12-15T19:26:44.000Z","date":"2016-12-13","kind":"exercise","acquired":true,"shares":10000,"price":26.1,"value":261000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":65743,"source":{"system":"sec-edgar","filing":"0001203311-16-000183","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331116000183/edgardoc.xml","form_type":"4"}},{"id":4604615,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2016-09-13T19:09:03.000Z","date":"2016-09-09","kind":"exercise","acquired":false,"shares":4167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares vested at a rate of 25% on 8/24/12 and monthly thereafter until all the shares were fully vested on 8/24/15."}],"balance_after":0,"derivative":{"exercise_price":15.46,"expiration_date":"2021-08-24","underlying":"Common Stock","underlying_shares":4167},"source":{"system":"sec-edgar","filing":"0001203311-16-000157","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331116000157/edgardoc.xml","form_type":"4"}},{"id":4604614,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2016-09-13T19:09:03.000Z","date":"2016-09-09","kind":"exercise","acquired":true,"shares":4167,"price":15.46,"value":64421.82,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":55743,"source":{"system":"sec-edgar","filing":"0001203311-16-000157","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331116000157/edgardoc.xml","form_type":"4"}},{"id":4608137,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2016-09-08T19:18:58.000Z","date":"2016-09-06","kind":"sale","acquired":false,"shares":771,"price":46.0165,"value":35478.7215,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":51576,"source":{"system":"sec-edgar","filing":"0001203311-16-000151","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331116000151/edgardoc.xml","form_type":"4"}},{"id":4608136,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":38545,"kind":"person","name":"Cline Darren S","position":1,"cik":"0001633639","reported_name":"Cline Darren S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2016-09-08T19:18:58.000Z","date":"2016-09-06","kind":"sale","acquired":false,"shares":4626,"price":46.007,"value":212828.382,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":52347,"source":{"system":"sec-edgar","filing":"0001203311-16-000151","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331116000151/edgardoc.xml","form_type":"4"}}]}